BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 22338083)

  • 21. Organic anion transporters involved in the excretion of bestatin in the kidney.
    Zhu Y; Meng Q; Wang C; Liu Q; Sun H; Kaku T; Liu K
    Peptides; 2012 Feb; 33(2):265-71. PubMed ID: 22273603
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ontogeny of expression of organic anion transporters 1 and 3 in ovine fetal and neonatal kidney.
    Wood CE; Cousins R; Zhang D; Keller-Wood M
    Exp Biol Med (Maywood); 2005 Oct; 230(9):668-73. PubMed ID: 16179735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional expression of pig renal organic anion transporter 3 (pOAT3).
    Hagos Y; Braun IM; Krick W; Burckhardt G; Bahn A
    Biochimie; 2005 May; 87(5):421-4. PubMed ID: 15820748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analyses of coding region polymorphisms in apical and basolateral human organic anion transporter (OAT) genes [OAT1 (NKT), OAT2, OAT3, OAT4, URAT (RST)].
    Xu G; Bhatnagar V; Wen G; Hamilton BA; Eraly SA; Nigam SK
    Kidney Int; 2005 Oct; 68(4):1491-9. PubMed ID: 16164626
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The contribution of organic anion transporters OAT1 and OAT3 to the renal uptake of rosuvastatin.
    Windass AS; Lowes S; Wang Y; Brown CD
    J Pharmacol Exp Ther; 2007 Sep; 322(3):1221-7. PubMed ID: 17585018
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification and Quantitative Assessment of Uremic Solutes as Inhibitors of Renal Organic Anion Transporters, OAT1 and OAT3.
    Hsueh CH; Yoshida K; Zhao P; Meyer TW; Zhang L; Huang SM; Giacomini KM
    Mol Pharm; 2016 Sep; 13(9):3130-40. PubMed ID: 27467266
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of a mechanism by which the methylmercury antidotes N-acetylcysteine and dimercaptopropanesulfonate enhance urinary metal excretion: transport by the renal organic anion transporter-1.
    Koh AS; Simmons-Willis TA; Pritchard JB; Grassl SM; Ballatori N
    Mol Pharmacol; 2002 Oct; 62(4):921-6. PubMed ID: 12237339
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drugs interacting with organic anion transporter-1 affect uptake of Tc-99m-mercaptoacetyl-triglycine (MAG3) in the human kidney: therapeutic drug interaction in Tc-99m-MAG3 diagnosis of renal function and possible application of Tc-99m-MAG3 for drug development.
    Takahara N; Saga T; Inubushi M; Kusuhara H; Seki C; Ito S; Oyama N; Yokoyama O; Sugiyama Y; Fujibayashi Y
    Nucl Med Biol; 2013 Jul; 40(5):643-50. PubMed ID: 23618840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transporter studies with the 3-O-sulfate conjugate of 17alpha-ethinylestradiol: assessment of human kidney drug transporters.
    Han YH; Busler D; Hong Y; Tian Y; Chen C; Rodrigues AD
    Drug Metab Dispos; 2010 Jul; 38(7):1064-71. PubMed ID: 20360303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oat1/3 restoration protects against renal damage after ischemic AKI.
    Schneider R; Meusel M; Betz B; Held C; Möller-Ehrlich K; Büttner-Herold M; Wanner C; Gekle M; Sauvant C
    Am J Physiol Renal Physiol; 2015 Feb; 308(3):F198-208. PubMed ID: 25391897
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential interactions of the β-lactam cloxacillin with human renal organic anion transporters (OATs).
    Lalanne S; Le Vée M; Lemaitre F; Le Corre P; Verdier MC; Fardel O
    Fundam Clin Pharmacol; 2020 Aug; 34(4):476-483. PubMed ID: 32100322
    [TBL] [Abstract][Full Text] [Related]  

  • 32. D-Malate decreases renal content of α-ketoglutarate, a driving force of organic anion transporters OAT1 and OAT3, resulting in inhibited tubular secretion of phenolsulfonphthalein, in rats.
    Uwai Y; Kawasaki T; Nabekura T
    Biopharm Drug Dispos; 2017 Nov; 38(8):479-485. PubMed ID: 28744858
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Precise comparison of protein localization among OCT, OAT, and MATE in human kidney.
    Motohashi H; Nakao Y; Masuda S; Katsura T; Kamba T; Ogawa O; Inui K
    J Pharm Sci; 2013 Sep; 102(9):3302-8. PubMed ID: 23630107
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of three-dimensional systems for developing and mature kidneys clarifies the role of OAT1 and OAT3 in antiviral handling.
    Nagle MA; Truong DM; Dnyanmote AV; Ahn SY; Eraly SA; Wu W; Nigam SK
    J Biol Chem; 2011 Jan; 286(1):243-51. PubMed ID: 20921221
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Investigation of Endogenous Compounds Applicable to Drug-Drug Interaction Studies Involving the Renal Organic Anion Transporters, OAT1 and OAT3, in Humans.
    Tsuruya Y; Kato K; Sano Y; Imamura Y; Maeda K; Kumagai Y; Sugiyama Y; Kusuhara H
    Drug Metab Dispos; 2016 Dec; 44(12):1925-1933. PubMed ID: 27638508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression and function of Oat1 and Oat3 in rat kidney exposed to mercuric chloride.
    Di Giusto G; Anzai N; Ruiz ML; Endou H; Torres AM
    Arch Toxicol; 2009 Oct; 83(10):887-97. PubMed ID: 19533102
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Caffeic acid inhibits organic anion transporters OAT1 and OAT3 in rat kidney.
    Uwai Y; Kawasaki T; Nabekura T
    Drug Metabol Drug Interact; 2013; 28(4):247-50. PubMed ID: 24166669
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug Clearance from Cerebrospinal Fluid Mediated by Organic Anion Transporters 1 (Slc22a6) and 3 (Slc22a8) at Arachnoid Membrane of Rats.
    Zhang Z; Tachikawa M; Uchida Y; Terasaki T
    Mol Pharm; 2018 Mar; 15(3):911-922. PubMed ID: 29436232
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Male-dominant activation of rat renal organic anion transporter 1 (Oat1) and 3 (Oat3) expression by transcription factor BCL6.
    Wegner W; Burckhardt BC; Burckhardt G; Henjakovic M
    PLoS One; 2012; 7(4):e35556. PubMed ID: 22530049
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 6β-Hydroxycortisol is an endogenous probe for evaluation of drug-drug interactions involving a multispecific renal organic anion transporter, OAT3/SLC22A8, in healthy subjects.
    Imamura Y; Tsuruya Y; Damme K; Heer D; Kumagai Y; Maeda K; Murayama N; Okudaira N; Kurihara A; Izumi T; Sugiyama Y; Kusuhara H
    Drug Metab Dispos; 2014 Apr; 42(4):685-94. PubMed ID: 24487120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.